AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2016
Dec 16, 2016
35323_dirs_2016-12-16_3950258b-befb-470c-bf5f-c330011dfcb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2016-12-15
Reporting Person: MILLER LLOYD I III (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-15 | Common Stock | S | 20000 | $0.04 | Disposed | 38967 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 472792 | Indirect |
| Common Stock | 90344 | Indirect |
| Common Stock | 641218 | Indirect |
| Common Stock | 724100 | Indirect |
| Common Stock | 5828968 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16